Nivolumab (IMAGE)

Osaka University

Nivolumab

Caption

Binding status of Nivolumab can be divided into three different types based on occupancy of PD-1 in T cells: complete binding, partial binding and no binding. PD-L1 can interact with T cells already in partial binding status.

Credit

Osaka University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.